Allopurinol in Acute Gout
NCT01775098 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2017-05-11
Summary
The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises
Conditions
Interventions
- DRUG
-
allopurinol
No arms will not be change as the study as been closed.
Sponsors & Collaborators
-
Université de Sherbrooke
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2012-12-31
- Completion
- 2013-02-28
More Related Trials
-
Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
NCT01310673 ·Status: COMPLETED ·Phase: PHASE4
-
Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
NCT04987294 ·Status: TERMINATED ·Phase: PHASE2
-
MPC-004 for the Treatment of an Acute Gout Flare
NCT00506883 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04956432 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout
NCT05256810 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Uric Acid and the Endothelium in CKD
NCT01228903 ·Status: COMPLETED ·Phase: NA
-
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
NCT00987415 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout
NCT06956885 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Allopurinol in Acute Coronary Syndrome
NCT01457820 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
NCT01736514 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932 ·Status: COMPLETED ·Phase: PHASE3
-
An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)
NCT04987242 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Administration of Allopurinol in Dialysis Patients
NCT02477488 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
NCT00174915 ·Status: COMPLETED ·Phase: PHASE3
-
PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
NCT00829829 ·Status: COMPLETED ·Phase: PHASE3
-
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
NCT01701622 ·Status: TERMINATED ·Phase: NA
-
Evaluation of PK and Safety of D-0120 and Allopurinol
NCT05360628 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prednisolone Versus Colchicine for Acute Gout in Primary Care
NCT05698680 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
NCT01451645 ·Status: COMPLETED ·Phase: PHASE4
-
Uric Acid and Hypertension in African Americans
NCT00241839 ·Status: COMPLETED ·Phase: PHASE3
-
Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
NCT04844814 ·Status: SUSPENDED ·Phase: PHASE2
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3
-
APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X
NCT00512057 ·Status: COMPLETED ·Phase: PHASE4
-
Center of Research Translation (CORT) Project 2
NCT02038179 ·Status: COMPLETED ·Phase: PHASE2/PHASE3